Clinical trial
Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP Survivors
NCT06358703 is registered in ClinicalTrials.gov with US Thrombotic Microangiopathy Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP Survivors
- Lead sponsor
- US Thrombotic Microangiopathy Alliance
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 31, 2024
- Completion date
- May 31, 2028
- Enrollment
- 116 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immune thrombotic thrombocytopenia